Get the Stockscreener App
0.9509
4.19%
-0.0416
Connect Biopharma Holdings Ltd Adr stock is traded at $0.9509, with a volume of 10,220.
It is down -4.19% in the last 24 hours and down -9.44% over the past month.
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
See More
Previous Close:
$0.9925
Open:
$0.9569
24h Volume:
10,220
Relative Volume:
0.37
Market Cap:
$52.54M
Revenue:
-
Net Income/Loss:
$-85.88M
P/E Ratio:
-0.6062
EPS:
-1.5686
Net Cash Flow:
$-80.96M
1W Performance:
-14.98%
1M Performance:
-9.44%
6M Performance:
-34.29%
1Y Performance:
+11.87%
1-Day Range:
$0.95
$0.9569
1-Week Range:
$0.95
$1.12
52-Week Range:
$0.77
$2.66
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Company Profile
Name
Connect Biopharma Holdings Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare CNTB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd Adr
|
0.9509 | 52.54M | 0 | -85.88M | -80.96M | -1.5686 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-24 | Initiated | H.C. Wainwright | Buy |
| Apr-13-21 | Initiated | Jefferies | Buy |
| Apr-13-21 | Initiated | Piper Sandler | Overweight |
| Apr-13-21 | Initiated | SVB Leerink | Outperform |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Latest News
Connect Biopharma shares hold at Buy after FDA meeting - Investing.com
Analyzing Stride (NYSE:LRN) & Visionary (NASDAQ:GV) - Defense World
CNTB Stock on the Rise: A Promising Investment - The InvestChronicle
Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum - GlobeNewswire Inc.
Connect Biopharma appoints new CEO and President By Investing.com - Investing.com
Connect Biopharma shares target raised on strategic focus By Investing.com - Investing.com
Are Medical Stocks Lagging Bausch Health (BHC) This Year? - MSN
Has Connect Biopharma Holdings (CNTB) Outpaced Other Medical Stocks This Year? - Yahoo Finance UK
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Making it harder to "buy" China, Inc. - US-China Institute
Connect Biopharma Holdings Limited: Shareholders Board Members Managers and Company Profile | US2075231017 - Marketscreener.com
Connect Biopharma Holdings Limited Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares - Yahoo Finance
Connect Biopharma (CNTB) Stock Price, News & Analysis - MarketBeat
BioLine Rx (NASDAQ:BLRX) Stock Quotes, Forecast and News Summary - Benzinga
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):